|
You have been chosen to receive this valuable information.
|
|
|
|
|
|
|
|
What are other sponsors doing for remote consent, data capture and engagement?
Which technologies can I implement to support remote site-patient interactions?
How can I protect data reliability when the patient isn't at the site?
|
|
|
What are other sponsors doing for remote consent, data capture and engagement?
Which technologies can I implement to support remote site-patient interactions?
How can I protect data reliability when the patient isn't at the site?
|
|
|
What are other sponsors doing for remote consent, data capture and engagement?
Which technologies can I implement to support remote site-patient interactions?
How can I protect data reliability when the patient isn't at the site?
|
|
|
|
What Changes Can You Make Right Now
To Minimize Clinical Trial Disruption?
|
|
|
Hi,
As COVID-19 temporarily dominates (and in some ways forever changes) the way we live and work, sponsors cannot simply stop ongoing or planned clinical trials. During candid conversations with our customers, sites, and regulators over the past few weeks we have learned a great deal about the challenges that arise when study patients and research staff must socially isolate.
If you are facing similar challenges and would like to speak with someone about your unique needs, please let us know. Whether you are a current customer or have never heard of Signant before, our experts are ready and available to help you navigate these uncertain times with consultation and solutions for...
Remote Assessments, Consent and Engagement | Data Management and Reliability | Available Technology to Adapt to New Trial Realities | IRT for Rapid Enrollment | Supply Chain Considerations
|
|
|
This is a complimentary and non-promotional conversation with the intent of collaborating and building our industry crisis response to mitigate the disruptive impact of COVID-19.
|
|
|
|
MEET THE TEAM
Meet our team of experts here to guide you during the COVID-19 Pandemic.
|
|
|
BILL BYROM, PhD
VP Product Strategy & Innovation
|
|
BARB ENGER, MSN
VP Clinical Science
|
|
|
|
JIM PRIMERANO
SVP & General Manager eClinical
|
|
DAN DEBONIS
Principal Endpoint Solutions
|
|
|
|
SCIENCE AND MEDICINE LEADERSHIP
David Daniel, MD | Steve Targum, MD | Joan Busner, PhD
Lew Fredane, MD | Denis Curtin, PhD | Amir Kalali, MD
Alan Kott, MUDr. | Dr David Miller, MD, MA
Gary Sachs, MD | Todd Everhart, MD
|
|
|
|
|
|
|
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Applied Clinical Trials, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
|
|
